Correction
27 Jan 2026: The PLOS One Editors (2026) Correction: Dementia and autopsy-verified causes of death in racially-diverse older Brazilians. PLOS ONE 21(1): e0341697. https://doi.org/10.1371/journal.pone.0341697 View correction
Figures
Abstract
Background
While dementia has been associated with specific causes of death, previous studies were relatively small autopsy series or population-based studies lacking autopsy confirmation and were restricted to Non-Latinx Whites. Here, we examine the association of dementia with autopsy-verified causes of death in racially-diverse older Brazilians.
Methods
As part of the Pathology, Alzheimer´s and Related Dementias Study (PARDoS), a community-based study in Brazil, we included 1941 racially-diverse deceased, 65 years or older at death. We conducted a structured interview with legal informants including the Clinical Dementia Rating (CDR) Scale for dementia proximate to death. Causes of death were assessed after full-body autopsy and macroscopic examination of the brain, thoracic and abdominal/pelvic organs. Up to four causes of death were reported for each decedent. Causes of death were classified as circulatory, infectious, cancer and other. Logistic regression was used to determine associations of dementia with cause of death, controlling for age, sex, race, and education.
Results
Dementia was associated with a higher odds of an infectious cause of death (OR = 1.81, 95%CI:1.45–2.25), and with a lower odds of a circulatory disease as cause of death (OR = 0.69, 95%CI:0.54–0.86) and cancer as cause of death (OR = 0.41, 95%CI:0.24–0.71). Dementia was associated with a higher odds of pneumonia (OR = 1.92, 95%CI:1.53–2.40) and pulmonary embolism (OR = 2.31, 95%CI:1.75–3.05) as causes of death and with a lower odds of acute myocardial infarction (OR = 0.42, 95%CI:0.31–0.56) and arterial disease (OR = 0.76, 95%CI:0.61–0.94) as causes of death.
Citation: Farfel JM, Leurgans SE, Capuano AW, de Moraes Sampaio MC, Wilson RS, Schneider JA, et al. (2021) Dementia and autopsy-verified causes of death in racially-diverse older Brazilians. PLoS ONE 16(12): e0261036. https://doi.org/10.1371/journal.pone.0261036
Editor: Xi Pan, Texas State University, UNITED STATES
Received: July 29, 2021; Accepted: November 22, 2021; Published: December 15, 2021
Copyright: © 2021 Farfel et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: Data can be requested at the Resource Sharing Hub of the Rush Alzheimer’s Disease Center (https://www.radc.rush.edu). After creating an account, all qualified investigators can request PARDoS data. According to RUSH Institutional Review Board policies, all requests will undergo a scientific review. A data use agreement signed by both RUSH and the recipient’s institution is required for data sharing and can be found at the same electronic address.
Funding: The study was funded by NIA grant R01AG54058 awarded to DAB as Principal Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Dementia is a chronic disabling condition affecting around 50 million people worldwide, the majority of whom live in low and middle-income countries [1]. Latin America is expected to have a greater increase in the prevalence of dementia than developed regions of the globe [2]. We and others have shown that dementia is associated with a higher mortality risk [3–6], and post-mortem studies have reported circulatory, neurologic and infectious diseases, mainly pneumonia, as the most common causes of death in persons with dementia [7–18].
Many groups previously examined differences in causes of death among demented and non-demented subjects and found that subjects with dementia were more likely to die from pneumonia and less likely to die from circulatory disease and cancer [7–18]. However, many of these studies were small autopsy series restricted to a few hundred cases with highly selected participants from tertiary care clinics [7–14]. Others were large population-based studies but lacked autopsy confirmation of the causes of death relying instead on death certificates [15–18]. Most of these studies were restricted to White Europeans living in developed countries. A recent cause-of-death national report in the US based on death certificated shows that the cause-of-death differs by race. While heart disease was the most common cause of death among non-Latinx Whites and Blacks, cancer was the most common cause of death among Latinx [19]. We are not aware of any previous study examining differences of causes of death between demented and non-demented subjects in a diverse population or in Latin America. Here, we use data from a large community-based, post-mortem study to examine the association of dementia with autopsy-confirmed causes of death in a racially-diverse sample of more than 2,000 older Brazilians.
Materials and methods
Decedents
Decedents were included from the Pathology, Alzheimer´s and Related Dementia Study (PARDoS). PARDoS enrolls decedents, 18 years or older, who died from non-forensic causes in the State of Sao Paulo. PARDoS is composed of two cross-sectional, community-based studies, with similar eligibility criteria and similar clinical data collection by the same staff facilitating efficient merging of the data, including the study having the same PARDoS name which started in 2020 at the Instituto de Assistencia Medica ao Servidor Publico Estadual (IAMSPE), and the study entitled “Study of Ancestry, Neurodegenerative Diseases and Stroke (SANDS)” which started in 2016 in another institution and was relocated to IAMSPE in 2020 after the former institution terminated its participation in the project in 2019. Both studies were approved by local ethical committees and by Comissão Nacional de Ética em Pesquisa (CONEP), the Brazilian federal ethics committee. Because the index cases were decedents, the study was determined to be of non-human subjects in the United States and IRB exempt in the USA. As previously described [20], enrollment for PARDoS takes place in the State of Sao Paulo and prioritizes Black/Mixed decedents who are 65 years or older at death, and White decedents with fewer than 9 years of education enriched with admixed ancestry. Many decedents, however, were born in different States. The States Paraná, Santa Catarina, and Rio Grande do Sul, located in the southern states of Brazil, are usually less admixed and for this reason, were given a lower priority. This prioritization was implemented by our nurse interviewers who did a screening of the demographics and place of birth before approaching the families.
In Brazil, the informants were considered human subjects of interest. Thus, nurses from the staff identified and approached legal representatives of the decedents to obtain consent while they were waiting for funeral arrangements. PARDoS consent rate was 39.7% of the representatives approached. Representatives who were not able to understand the consent or who were overly distraught were not included. A signed consent, a death certificate filled with autopsy-verified causes of death, and a valid cognitive assessment obtained with an informant were available for 1941 decedents aged 65 years or older at the time of the analyses. The mean age at death of decedents was 79.9 years (SD = 8.9 years; range: 65–106 years) and the mean educational attainment was 4.9 years (SD = 3.8 years; range: 0–25 years); 46.7% of the decedents were women and 31.2% were informant-declared Black (10.0%) or Mixed (21.2%).
Clinical interview
The informant was asked by a nurse interviewer to participate in an 60-90-minute interview immediately following consent. The clinical interview collects information about the deceased including demographics, and a cognitive assessment using validated questionnaires as detailed below. More than one informant was allowed to participate in the interview; however, the interviewer prioritized answers provided by the informant whose relationship with the decedent was closest and had the most contact with the decedent.
The date of birth and sex were obtained from the decedent’s identification documents; age at death was calculated. Informant-report race was classified as Black, Mixed, or White, according to the Brazilian census criteria [21]. We combined the Black and Mixed groups into one group referred to as Black in this study, following the criteria used by previous authors, for which Mixed race is not a formal census choice. The informant also reported education as the number of years the decedent attended school.
The relationship of the informant to the decedent was recorded, as well as the average number of days a week that the informant had contact with the decedent over the year prior to death and the estimated number of years the informant knew the decedent. Most of the informants were children (75.5%), followed by grandchildren (9.2%), siblings (4.5%), spouses (3.0%), and other (7.8%). Informants knew the decedents for an average of 47.0 years (SD: 12.3) and had contact with the decedents for an average of 2.4 (SD: 3.9) days per week.
Assessment of dementia and cognitive impairment
The Clinical Dementia Rating (CDR) Scale was used for the diagnosis of dementia proximate to death [22]. We used the informant-specific sections of the CDR structured questionnaire for each of the six cognitive domains of the scale (i.e., memory, orientation, judgment, and problem solving, community affairs, home and hobbies, personal care). Each of the domains was scored on a 5‐point scale as follows: 0, no impairment; 0.5, questionable impairment; 1, mild impairment; 2, moderate impairment; and 3, severe impairment (personal care was scored on a 4‐point scale combining 0 and 0.5 ratings). An algorithm combined the level of the domains affected and resulted in an overall score. A diagnosis of dementia required a CDR > 0.5.
Autopsy-based causes of death
Brazilian law mandates a full-body autopsy examination for non-forensic cases for persons who cannot obtain a death certificate from a physician. The autopsy procedures include removal, sectioning and macroscopic inspection of the brain, and all thoracic, including lungs and heart and abdominal/pelvic organs, including liver, gallbladder, spleen, pancreas, kidneys, intestines, bladder and sexual organs. The brain and multiple sections were also photographed by the study staff and the images were made available to the medical examiner. Only macroscopic examination was used to determine the causes of death. Microscopic examination was not used for confirming macroscopic findings. The causes of death were determined during the autopsy by the medical examiner who record them in a death certificate required for starting funeral procedures. The examiner was blinded to the clinical interview performed by our staff with informants and had access to very limited medical records which were sometimes used to support secondary causes of death but not the primary cause. The death certificate allows up to four causes of death, starting with the basic or primary cause of death which triggers the sequence of other causes. The causes of death are hand-written by the medical examiner in open fields. Each cause of death was entered in our database and converted to its corresponding International Classification of Diseases (ICD-10) code. While the medical examiners did not follow strict rules, the coding of ICD-10 was done in a structured manner by PARDoS staff. The average number of causes of death reported in our study was 2.02 per case (range 1–4) with 63.6% reporting a second cause, 32.5% reporting a third cause and 11.1% reporting a fourth cause of death. All cases showing signs of trauma were forensic cases and excluded and referred to the forensic medical examiner.
For analysis, we divided causes of death into four major groups: 1. Diseases of the circulatory system (according to the section I. of the ICD-10 (I.00 - I.99)), including heart conditions such as heart failure, hypertensive heart disease, ischemic heart disease; arterial conditions such as regional or systemic atherosclerosis, acute myocardial infarction, acute and chronic strokes; and venous conditions including pulmonary embolism; 2. Infectious diseases included diverse sections of the ICD-10 of infectious origin; 3. Cancer (according to section C. of the ICD-10 (C.00 – C.97)); and 4. Other causes including chronic pulmonary disease such as asthma or chronic obstructive pulmonary disease, chronic kidney failure, cirrhosis, among others.
Statistical analysis
We first examined the association of dementia with all causes of death by building unadjusted logistic regression models. Three separate models were built using the categories of circulatory disease, infectious disease and cancer as outcomes. We repeated the models for the three groups using only the primary cause of death as a secondary outcome. Next, we built similar models using the specific ICD-10 codes of the five most reported causes of death: 1. heart disease including congestive heart failure, hypertensive and ischemic heart diseases; 2. pneumonia; 3. acute myocardial infarct; 4. arterial disease including significant focal and systemic atherosclerosis; 5. and pulmonary embolism. We repeated the models by adjusting for age at death, sex, education, and race. White race was used as the reference group. Age of death is the most important predictor of dementia [23, 24]. Education is a very established promotor of cognitive reserve, that protects against dementia [25, 26]. Sex and race have also been shown to be related to differential odds of having dementia [27, 28]. We now add unadjusted models into the paper as per the reviewer’s recommendation. These demographic factors may also be associated with specific causes of death. Age is the most important risk factor for cancer incidence and many cancer types [29]. Cardiovascular risk factors and circulatory disease are usually more prevalent in men and African Americans [30]. Lower education is associated with poorer control of cardiovascular risk factors [31]. Finally, to test whether the association of dementia with the groups of cause of death were modified by race we repeated logistic regression models with additional term for the interaction of race and dementia. All analyses considered a nominal threshold of p < 0.05 to determine significance and were conducted using SAS/STAT software, Version 9.4 of the SAS® system for Linux.
Results
Demographic, clinical characteristics and causes of death are shown in Table 1. Circulatory disease was the most common cause of death when all causes were analyzed, affecting more than three quarters of the sample. Infectious diseases contributed to the cause of death in approximately a quarter of the decedents and cancer in approximately 5%. Circulatory disease was also the most common primary cause of death in two thirds of the cases, followed by infectious diseases in nearly a quarter and cancer in fewer than 5% of the cases. We searched for differences in causes of death by race. We did not find any significant difference of causes of death between Blacks and Whites when considering the major groups of causes and the five more common causes of death verified (all p’s > 0.05).
Association of dementia with cause of death categories
Table 2 shows the distribution of causes of death in those with and without dementia and the unadjusted logistic regression models examining the association of dementia and causes of death. Circulatory disease was the most frequent cause of death in both demented and non-demented subjects. However, subjects with dementia were less likely to die from circulatory cause of death compared to subjects without dementia. Similar findings were observed when only the primary causes of death were included. Infectious diseases followed circulatory diseases as the second most common group of diseases causing death both in demented and non-demented subjects. In contrast to the findings for circulatory disease, subjects with dementia were more likely to die from infectious diseases when compared to non-demented both when all causes of death were analyzed and when only primary cause was considered. Finally, cancer was the least common cause of death of the three groups of diseases in both demented and non-demented. Similar to the finding for circulatory diseases, demented subjects were less likely to die from cancer compared to non-demented when all causes were considered and when just the primary cause was considered.
Next, we built logistic regression models adjusted for age at death, sex, education, and race to examine the association of dementia with cause of death. We built separate models for each of the three groups of causes of death (circulatory, infectious and cancer). Dementia was associated with a higher odds of an infectious cause of death (OR: 1.81, 95%CI: 1.44–2.25) and lower odds of a circulatory disease (OR: 0.69, 95%CI: 0.54–0.86, p = 0.001) and cancer (OR: 0.41, 95%CI: 0.24–0.71) as causes of death (Table 3). Similar results were found when using only primary cause of death (S1 Table).
We also examined whether race modified the association of dementia with cause of death by adding an interaction term of race and dementia in the models. The interaction of race and dementia was not significant in any of the models (all p’s > 0.05)
Association of dementia with the top five causes of death
Among the five most common specific diseases reported as causes of death, subjects with dementia were more likely to die from pneumonia and pulmonary embolism and less likely to die from acute myocardial infarct and atherosclerosis when compared to non-demented subjects. There was no difference for likelihood of having a heart disease as cause of death between demented and non-demented (Table 2). The results were similar when the primary cause of death was examined. The association of dementia with atherosclerosis as a primary cause of death was not examined as atherosclerosis was a rare primary cause of death.
We also built logistic models to examine the association of dementia with the five most common causes of death adjusted for age at death, sex, race and education. Dementia more than doubled the odds of pneumonia (OR: 2.10, 95%CI: 1.64–2.68) or pulmonary embolism (OR: 2.31, 95%CI: 1.75–3.05) as causes of death and was associated with a lower odds of myocardial infarct (OR: 0.42, 95%CI: 0.31–0.56) or atherosclerosis (OR: 0.76, 95%CI: 0.61–0.94) as causes of death. We did not find any association of dementia with heart disease (OR: 0.89, 95%CI: 0.73–1.09).
Finally, we examined whether race modified the association of dementia with the five most common causes of death. The interaction of race and dementia was not significant in any of the models (all p’s > 0.05).
Discussion
In this study, nearly 2,000 older decedents enrolled in a community-based study on aging and dementia in the state of Sao Paulo, Brazil, underwent full-body autopsy to determine the causes of their death and their informants were interviewed to provide the diagnosis of dementia using validated scales. We found that dementia is associated with a higher odds of an infectious disease as cause of death, especially pneumonia and with a lower odds of cancer or circulatory disease as causes of death, especially atherosclerosis and acute myocardial infarction.
Previous studies found that the causes of death occurring in subjects with dementia may differ from the causes of death occurring in those without dementia [7–18]. However, most of these studies were either small autopsy-based case-control studies comparing highly-selected demented and non-demented from clinics [7–14], or were large population-based studies in developed countries that lacked autopsy confirmation of the causes of death in all or most of the decedents [15–18]. Further, these studies were performed in developed countries and included a vast majority of White Americans or Europeans. Here, we extend the findings of prior studies in three important ways. First, we increase confidence in our results by confirming the causes of death by a full-body autopsy with macroscopic examination of the brain, and all the organs in the thoracic and abdominal/pelvic cavities. Second, we take advantage of a sample recruited from the community to increase the generalizability of our results. Third, we include a racially-diverse sample with a wide range of educational and socioeconomic backgrounds from a South American Latin country.
Although we found that decedents with dementia had a lower odds of circulatory diseases as causes of death than decedents without dementia, this group of circulatory diseases was by far the leading causes of death both in those with and without dementia. Even in the subjects with dementia, it accounted for nearly two thirds of the deaths as the primary cause. Thus, the importance of circulatory disease to mortality of subjects suffering from dementia cannot be underestimated. Our finding is consistent with other studies showing circulatory diseases as one of the leading causes of mortality in dementia [7–18]. However, we found a higher frequency of circulatory disease as cause of death compared to other studies. The higher frequency of circulatory causes may be related to the distinct profile of our sample with lower education and socioeconomic status which are associated with higher circulatory risk. Further, the autopsy examiner had limited access to minimal clinical data and the microscopic examination was not used for confirming the cause of death [32]. When the group of circulatory diseases was dissected into more specific diagnosis, dementia had a different effect on different circulatory diseases. While dementia was associated with a higher likelihood of venous diseases like pulmonary embolism as cause of death, it was associated with a lower likelihood of arterial diseases such as atherosclerosis and acute myocardial infarction as causes of death. While the lower mobility resulting from dementia may be associated with a higher risk of death from venous thrombosis and pulmonary embolism [33]. The factors associated with a lower mortality due to arterial diseases in demented subjects deserves future investigation with more detailed information on the severity, region and type of arterial disease.
The finding of an association of dementia with a higher odds of an infectious disease as cause of death, especially of pneumonia is supported by prior literature [34]. Pneumonia is particularly more common in advanced stages of dementia when dysphagia is present increasing the risk of aspiration pneumonia [35, 36]. Our finding that dementia is associated with a lower odds of cancer as cause of death is also consistent with the findings from other studies [16–18]. Epidemiologic data from our group and others have suggested an inverse association between dementia and cancer [37–40]. Our study only examined macroscopic cancers and only reported cancers thought to be the cause of death. This in no way reflects the number of people who die with cancer. The same is true for all of the causes of death. Further, the frequency of cancer in our sample may be lower compared to other studies as many subjects dying from cancer already had the cause of death clinically confirmed by their physicians and autopsy was not required in these cases according to Brazilian law. Microscopic tumors or those that were not advanced enough to contribute to death were not reported. However, cancer was the cause of death in more than 5% of the decedents in our study and the organs where most common tumors occur were macroscopically examined. Thus, our findings lend further support to evidence of an inverse relationship between dementia and cancer.
A major strength of this study is the use full-body autopsy to identify causes of death in a large community-based and racially-diverse sample of older Brazilians. Our findings may help allocate resources to prevent causes of death associated with dementia. As circulatory diseases were the most common causes of death in subjects with dementia, the diagnosis, and treatment of cardiovascular risk factors should not be neglected after the diagnosis of dementia. Further, our findings showing that an infectious cause of death is more common in subjects with dementia reinforce the importance of preventive strategies for these conditions, especially for pneumonia. Vaccination, dysphasia assessment, oral hygiene, diet modifications, review of prescribed medications are among the preventive strategies that may reduce the deaths of subjects with dementia by infectious diseases [41–46]. The study also has important limitations. First, autopsy is the gold-standard method to detect causes of death; however, there are causes that are difficult to identify at autopsy. Such causes include some infectious diseases like urinary infection or sepsis that generates non-specific changes in organs and can be better verified by microbiology, or others conditions requiring toxicology, or hypoxic-ischemic brain injury from cardiorespiratory failure. Second, the causes of death are based only in macroscopic examination of the body and the organs. Microscopic examination could confirm or give additional information on the causes of death. Third, some patients with clinically identified cause of death do not come to the autopsy service and this could limit the generalizability of our findings. Forth, we did not examine the survival time between the diagnosis of dementia and death. Finally, we used an informant-based structured interview for the diagnosis of dementia instead of cognitive testing with living subjects. However, informant-based CDR has been previously reported to be highly correlated with antemortem diagnosis and neuropsychological testing [47–49].
Supporting information
S1 Table. Logistic regression models for the association of dementia and primary causes of death adjusted for age at death, sex, education and race, OR (95%CI).
https://doi.org/10.1371/journal.pone.0261036.s001
(DOCX)
Acknowledgments
The authors thank the thousands of Brazilian informants who participated in this study. We thank the staff of PARDoS and the Rush Alzheimer’s Disease Center for their support. We thank the Núcleo de Estudos, Pesquisa e Assessoria à Saúde (NEPAS), the Autopsy Service (SVO) at Santo André, and the Instituto de Assistência Médica ao Servidor Publico Estadual (IAMSPE), where the project is now located and active. We also thank the Fundação Faculdade de Medicina (FFM), the Autopsy Service (SVOC) at the University of São Paulo’s (USP), and its Medical School (FMUSP), where the project was conducted until September 5, 2019.
References
- 1. Prince M, Prina M, Guerchet M. World Alzheimer Report. Journey of Caring. An analysis of long-term care for dementia. 2013. Alzheimer’s Disease International. Available from: https://www.alzint.org/u/WorldAlzheimerReport2013.pdf.
- 2. Parra MA, Baez S, Allegri R, Nitrini R, Lopera F, Slachevsky A, et al. Dementia in Latin America: Assessing the present and envisioning the future. Neurology 2018;90: 222–231. pmid:29305437
- 3. James BD, Leurgans SE, Hebert LE, Scherr PA, Yaffe K, Bennett DA. Contribution of Alzheimer disease to mortality in the United States. Neurology 2014;82: 1045–1050. pmid:24598707
- 4. Brookmeyer R, Corrada MM, Curriero FC, Kawas C. Survival following a diagnosis of Alzheimer disease. Arch Neurol. 2002;59: 1764–7.3. pmid:12433264
- 5. Ganguli M, Dodge HH, Shen C, Pandav RS, DeKosky ST. Alzheimer disease and mortality: a 15-year epidemiological study. Arch Neurol. 2005;62: 779–84. pmid:15883266
- 6. Tschanz JT, Corcoran C, Skoog I, Khachaturian AS, Herrick J, Hayden KM, et al. Cache County Study Group. Dementia: the leading predictor of death in a defined elderly population: the Cache County Study. Neurology 2004;62: 1156–1162. pmid:15079016
- 7. Beard CM, Kokmen E, Sigler C, Smith GE, Petterson T, O’Brien PC. Cause of death in Alzheimer’s disease. Ann Epidemiol. 1996;6: 195–200.7. pmid:8827154
- 8. Kammoun S, Gold G, Bouras C, Giannakopoulos P, McGee W, Herrmann F, et al. Immediate causes of death of demented and non-demented elderly. Acta Neurol Scand Suppl. 2000;176: 96–9. pmid:11261812.
- 9. Brunnstrom HR, Englund EM. Cause of death in patients with dementia disorders. Eur J Neurol. 2009;16: 488–92.9. pmid:19170740
- 10. Attems J, Konig C, Huber M, Lintner F, Jellinger KA. Cause of death in demented and non-demented elderly inpatients; an autopsy study of 308 cases. J Alzheimers Dis. 2005;8: 57–62.10. pmid:16155350
- 11. Fu C, Chute DJ, Farag ES, Garakian J, Cummings JL, Vinters HV. Comorbidity in dementia: an autopsy study. Arch Pathol Lab Med. 2004;128: 32–8.11. pmid:14692815
- 12. Keene J, Hope T, Fairburn CG, Jacoby R. Death and dementia. Int J Geriatr Psychiatry. 2001;16: 969–74. pmid:11607941
- 13. Degerskär ANW, Englund EM. Cause of death in autopsy-confirmed dementia disorders. Eur J Neurol. 2020;27: 2415–2421. Epub 2020 Aug 31. pmid:32692883.
- 14. Newens AJ, Forster DP, Kay DW. Death certification after a diagnosis of presenile dementia. J Epidemiol Community Health. 1993;47: 293–7. pmid:8228765
- 15. Garcia-Ptacek S, Kareholt I, Cermakova P, Rizzuto D, Religa D, Eriksdotter M. Causes of death according to death certificates in individuals with dementia: A cohort from the Swedish dementia registry. J Am Geriatr Soc. 2016;64: e142. pmid:27801938
- 16. Van de Vorst IE, Koek HL, Bots ML, Vaartjes I. Evaluation of Underlying Causes of Death in Patients with Dementia to Support Targeted Advance Care Planning. J Alzheimers Dis. 2016;53: 117–25. pmid:27163802.
- 17. Tolppanen AM, Taipale H, Koponen M, Tiihonen J, Hartikainen S. Causes of death in a nationwide cohort of community-dwellers with Alzheimer’s disease. BMC Geriatr. 2020;20: 441. pmid:33138782; PMCID: PMC7607696.
- 18. Chamandy N, Wolfson C. Underlying cause of death in demented and non-demented elderly Canadians. Neuroepidemiology 2005;25: 75–84. Epub 2005 Jun 8. pmid:15947494.
- 19. Heron M. Deaths: Leading Causes for 2016. Natl Vital Stat Rep. 2018;67: 1–77. pmid:30248017.
- 20. Capuano AW, Wilson RS, Leurgans SE, Sampaio C, Barnes LL, Farfel JM, et al. Neuroticism, negative life events, and dementia in older White and Black Brazilians. Int J Geriatr Psychiatry 2021;36: 901–908. pmid:33377540
- 21.
Instituto Brasileiro de Geografia e Estatistica. 2021 [Cited on May 5, 2021]. Available from https://educa.ibge.gov.br/jovens/conheca-o-brasil/populacao/18319-cor-ou-raca.html.
- 22. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43: 2412–2414. pmid:8232972
- 23. Kawas C, Gray S, Brookmeyer R, Fozard J, Zonderman A. Age-specific incidence rates of Alzheimer’s disease: the Baltimore longitudinal study of aging. Neurology. 2000;54: 2072–2077. pmid:10851365
- 24. Lobo A, Launer LJ, Fratiglioni L, Andersen K, Di Carlo A, Breteler MM, et al. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic diseases in the elderly research group. Neurology. 2000;54: S4–S9. pmid:10854354
- 25. Crimmins E. M., Saito Y., Kim J. K., Zhang Y. S., Sasson I., & Hayward M. D. (2018). Educational Differences in the Prevalence of Dementia and Life Expectancy with Dementia: Changes from 2000 to 2010. J Gerontol B Psychol Sci Soc Sci. 2018;73: S20–S28. pmid:29669097
- 26. Fratiglioni L, Grut M, Forsell Y, Viitanen M, Grafström M, Holmén K, et al. Prevalence of Alzheimer’s disease and other dementias in an elderly urban population: relationship with age, sex, and education. Neurology 1991;41: 1886–1892. pmid:1745343
- 27. Mazure CM, Swendsen J. Sex differences in Alzheimer’s disease and other dementias. Lancet Neurol. 2016;15(5): 451–452. pmid:26987699
- 28. Matthews KA, Xu W, Gaglioti AH, Holt JB, Croft JB, Mack D, et al. Racial and ethnic estimates of Alzheimer’s disease and related dementias in the United States (2015–2060) in adults aged ≥65 years. Alzheimers Dement. 2019;15: 17–24. pmid:30243772
- 29.
National Cancer Institute. 2021 [Cited on October 8th, 2021]. Available from https://www.cancer.gov/about-cancer/causes-prevention/risk/age.
- 30. Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, et al.; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association. Circulation. 2018;137: e67–e492. pmid:29386200
- 31. Kubota Y, Heiss G, MacLehose RF, Roetker NS, Folsom AR. Association of Educational Attainment With Lifetime Risk of Cardiovascular Disease: The Atherosclerosis Risk in Communities Study. JAMA Intern Med. 2017;177: 1165–1172. pmid:28604921
- 32. Stringhini S, Carmeli C, Jokela M, Avendaño M, Muennig P, Guida F, et al. LIFEPATH consortium. Socioeconomic status and the 25 × 25 risk factors as determinants of premature mortality: a multicohort study and meta-analysis of 1·7 million men and women. Lancet 2017;389: 1229–1237. pmid:28159391
- 33. Pottier P, Hardouin JB, Lejeune S, Jolliet P, Gillet B, Planchon B. Immobilization and the risk of venous thromboembolism. Ameta-analysis on epidemiological studies. Thromb Res 2009;124: 468–476. pmid:19481781
- 34. Manabe T, Fujikura Y, Mizukami K, Akatsu H, Kudo K. Pneumonia-associated death in patients with dementia: A systematic review and meta-analysis. PLoS ONE. 2019 14(3): e0213825. pmid:30870526
- 35. Manabe T, Teramoto S, Tamiya N, Okochi J, Hizawa N. Risk Factors for Aspiration Pneumonia in Older Adults. PLoS ONE 2015;10: e0140060. pmid:26444916
- 36. Beach TG, Russell A, Sue LI, Intorcia AJ, Glass MJ, Walker JE, et al. Increased Risk of Autopsy-Proven Pneumonia with Sex, Season and Neurodegenerative Disease. medRxiv: the preprint server for health sciences, 2021.01.07.21249410. pmid:33442709
- 37. Roe CM, Fitzpatrick AL, Xiong C, Sieh W, Kuller L, Miller JP, et al. Cancer linked to Alzheimer disease but not vascular dementia. Neurology 2010;74: 106–112. pmid:20032288
- 38. Yarchoan M, James BD, Shah RC, Arvanitakis Z, Wilson RS, Schneider J, et al. Association of Cancer History with Alzheimer’s Disease Dementia and Neuropathology. J Alzheimers Dis 2017;56: 699–706. pmid:28035936
- 39. Musicco M, Adorni F, Di Santo S, Prinelli F, Pettenati C, Caltagirone C, et al. Inverse occurrence of cancer and Alzheimer disease: A population-based incidence study. Neurology 2013;81: 322–328. pmid:23843468
- 40. Driver JA, Beiser A, Au R, Kreger BE, Splansky GL, Kurth T, et al. Inverse association between cancer and Alzheimer’s disease: Results from the Framingham Heart Study. BMJ 2012;344: e1442. pmid:22411920
- 41. Jackson LA, Neuzil KM, Yu O, Benson P, Barlow WE, Adams AL, et al. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med. 2003;348: 1747–1755. pmid:12724480
- 42. Marik PE, Kaplan D. Aspiration pneumonia and dysphagia in the elderly. Chest. 2003; 124:328–336. pmid:12853541
- 43. Mojon P, Budtz-Jorgensen E, Rapin CH. Relationship between oral health and nutrition in very old people. Age Ageing 1999;28: 463–468. pmid:10529041
- 44. Savoca MR, Arcury TA, Leng X, Chen H, Bell RA, Anderson AM, et al. Food avoidance and food modification practices due to oral health problems linked to the dietary quality of older adults. J Am Geriatr Soc. 2010;58: 1225–1232. pmid:20533966
- 45. Chen TY, Winkelman JW, Mao WC, Liu CL, Hsu CY, Wu CS, et al. The use of benzodiazepine receptor agonists and the risk of hospitalization for pneumonia: a nationwide population-based nested case–control study. Chest 2018;153: 161–171. pmid:28782528
- 46. Trifirò G, Gambassi G, Sen EF, Caputi AP, Bagnardi V, Brea J, Association of community-acquired pneumonia with antipsychotic drug use in elderly patients: a nested case–control study. Ann Intern Med 2010;152: 418–425. pmid:20368647
- 47. Davis PB, White H, Price JL, McKeel D, Robins LN. Retrospective postmortem dementia assessment. Validation of a new clinical interview to assist neuropathologic study. Arch Neurol. 1991 Jun;48(6): 613–7. pmid:2039384.
- 48. Waite L, Grayson D, Jorm AF, Creasey H, Cullen J, Bennett H, et al. Informant-based staging of dementia using the clinical dementia rating. Alzheimer Dis Assoc Disord. 1999 Jan;13(1): 34–7. pmid:10192640
- 49. Ferretti REL, Damin AE, Brucki SMD, Morillo LM, Perroco TR, Campora , et al. Post-Mortem diagnosis of dementia by informant interview. Dement Neuropsychol. 2010;4: 138–144. pmid:29213677